Investors

Investors

ConvaTec is a global medical products and technologies company with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes, and reduced total cost of care. ConvaTec has more than 9,000 employees, with 11 manufacturing sites in 8 countries, and does business in more than 100 countries. ConvaTec is owned by Nordic Capital and Avista Capital Partners.

The information contained in this section is considered accurate at the time of posting and may contain forward looking statements. The company maintains the archives of the material at the state it was distributed and does not update previously disseminated news releases or reports. By clicking on a document, you acknowledge that the information may no longer be accurate.

To sign up for email updates, enter your contact information below.

Cookies are needed for this website to work optimally. They also help us to know a little bit about how you use our website, which improves the browsing experience.  Cookies on this site are used for traffic measurement and optimisation of page content only. By continuing to browse on this website, you indicate your consent to the use of cookies.  You may block the use of cookies by following the "How to block and avoid cookies" instructions

Learn more about our Cookie policy